Literature DB >> 21384230

Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?

Pilar Giraldo1, Jose Luis Capablo, Pilar Alfonso, Beatriz Garcia-Rodriguez, Paz Latre, Pilar Irun, Alicia Saenz de Cabezon, Miguel Pocovi.   

Abstract

Gaucher disease (GD) is an autosomal recessive disorder characterized by defective function of glucocerebrosidase. GD presents a wide spectrum of manifestations, and patients and their relatives may develop neurological abnormalities more frequently than the general population. This study aims to determine the presence of neurological symptoms (NS) and Parkinson's disease (PD) in Spanish GD patients and their relatives. We surveyed 87 GD Spanish families and validated the information obtained on the neurological involvement through their physicians, as well as the historical data included in the Spanish Gaucher Disease Registry. Neurological abnormalities were correlated with the genetic characteristics. Statistical analyses included descriptive parameters, ANOVA, t-test, correlation study and Pearson coefficient. Information was obtained from 118 patients and 324 relatives. Out of 110 patients with type 1 GD, 32 (29.1%) reported NS and 7 (6.4%) had PD. In relatives, a total of 39 (13.1%) subjects had NS, including 16 with PD (5.3%). The prevalence of NS in genetic carriers (15.9%) was greater than that in non-carriers (5.9%; p < 0.01). Patients with PD carried the following GBA mutations: S364R, D409H, L444P, R257Q, IVS4-2A > G, c.500insT, and L336P. Relatives with PD exhibited a wide spectrum of mutations: L444P, N370S, V398I, R257Q, G202R, c.1439-1445del7, [E326K; N188S], and c.953delT. We observed a high incidence of PD in type 1 GD and relative's carriers. PD was more frequent in carriers of L444P and other rare GBA mutations. Therefore, it is important to perform a systematic neurological exam in patients with type 1 GD and carriers with high risk mutations.

Entities:  

Mesh:

Year:  2011        PMID: 21384230     DOI: 10.1007/s10545-011-9298-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.

Authors:  Assaf Halperin; Deborah Elstein; Ari Zimran
Journal:  Blood Cells Mol Dis       Date:  2006-05-02       Impact factor: 3.039

2.  Dopaminergic neuronal dysfunction associated with parkinsonism in both a Gaucher disease patient and a carrier.

Authors:  Satoshi Kono; Kentaro Shirakawa; Yasuomi Ouchi; Masanobu Sakamoto; Hiroyuki Ida; Takeshi Sugiura; Hiroyuki Tomiyama; Hitoshi Suzuki; Yoshitomo Takahashi; Hiroaki Miyajima; Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neurol Sci       Date:  2006-12-19       Impact factor: 3.181

3.  Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?

Authors:  A Halperin; D Elstein; A Zimran
Journal:  Acta Neurol Scand       Date:  2007-04       Impact factor: 3.209

4.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

5.  [Neurological manifestations in patients with Gaucher disease and in their relatives].

Authors:  Pilar Giraldo; José Luis Capablo; Pilar Alfonso; Paz Latre; Beatriz García; Miguel Pocoví
Journal:  Med Clin (Barc)       Date:  2008-07-05       Impact factor: 1.725

Review 6.  Gaucher disease: complexity in a "simple" disorder.

Authors:  Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

7.  Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia.

Authors:  M Pocovi; A Cenarro; F Civeira; M A Torralba; J I Perez-Calvo; P Mozas; P Giraldo; M Giralt; R H Myers; L A Cupples; J M Ordovas
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

8.  Neurological evaluation of patients with Gaucher disease diagnosed as type 1.

Authors:  J L Capablo; A Saenz de Cabezón; J Fraile; P Alfonso; M Pocovi; P Giraldo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

Review 9.  Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain.

Authors:  Pilar Alfonso; Sofía Aznarez; Manuel Giralt; Miguel Pocovi; Pilar Giraldo
Journal:  J Hum Genet       Date:  2007-04-11       Impact factor: 3.172

10.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

View more
  10 in total

1.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

2.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

Authors:  Roy N Alcalay; Oren A Levy; Cheryl C Waters; Stanley Fahn; Blair Ford; Sheng-Han Kuo; Pietro Mazzoni; Michael W Pauciulo; William C Nichols; Ziv Gan-Or; Guy A Rouleau; Wendy K Chung; Pavlina Wolf; Petra Oliva; Joan Keutzer; Karen Marder; Xiaokui Zhang
Journal:  Brain       Date:  2015-06-27       Impact factor: 13.501

3.  Greater risk of parkinsonism associated with non-N370S GBA1 mutations.

Authors:  M J Barrett; P Giraldo; J L Capablo; P Alfonso; P Irun; B Garcia-Rodriguez; M Pocovi; G M Pastores
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

4.  Glucocerebrosidase and parkinsonism: lessons to learn.

Authors:  Ivanka Marković; Nikola Kresojević; Vladimir S Kostić
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

5.  Proton MR Spectroscopy of the brain in children with neuronopathic Gaucher's disease.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Nahed Abdel Gaber; Abeer Fathy; Ahmed Megahed; Tarek Barakat; Mona Abdel Latif Alsayed
Journal:  Eur Radiol       Date:  2013-06-20       Impact factor: 5.315

6.  Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.

Authors:  Huma Q Rana; Manisha Balwani; Louise Bier; Roy N Alcalay
Journal:  Genet Med       Date:  2012-08-30       Impact factor: 8.822

7.  Pitfalls in the diagnosis of Gaucher disease in Iraq: A diagnostic experience from a developing country.

Authors:  Rabab Farhan Thejeal; Saja Baheer Abdul Wahhab; Nebal Waill Saadi
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

8.  Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.

Authors:  Pilar Giraldo; Pilar Alfonso; Pilar Irún; Laura Gort; Amparo Chabás; Lluïsa Vilageliu; Daniel Grinberg; Clara M Sá Miranda; Miguel Pocovi
Journal:  Orphanet J Rare Dis       Date:  2012-03-19       Impact factor: 4.123

Review 9.  Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency.

Authors:  Emilia M Gatto; Gustavo Da Prat; Jose Luis Etcheverry; Guillermo Drelichman; Martin Cesarini
Journal:  Brain Sci       Date:  2019-02-01

10.  Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS.

Authors:  Inna Bendikov-Bar; Debora Rapaport; Sarit Larisch; Mia Horowitz
Journal:  Orphanet J Rare Dis       Date:  2014-06-16       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.